Modeling the economic burden of postpartum hemorrhage due to substandard uterotonics in Ghana
Open Access
- 20 June 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (6) , e0003181
Abstract
Uterotonics are essential in preventing postpartum hemorrhage (PPH), the leading direct cause of maternal death worldwide. However, uterotonics are often substandard in low- and middle-income countries, contributing to poor maternal health outcomes. This study examines the health and economic impact of substandard uterotonics in Ghana. A decision-tree model was built to simulate vaginal and cesarean section births across health facilities, uterotonic quality and utilization, PPH risk and diagnosis, and resulting health and economic outcomes. We utilized delivery data from Ghana’s maternal health survey, risks of health outcomes from a Cochrane review, and E-MOTIVE trial data for health outcomes related to oxytocin quality. We compared scenarios with and without substandard uterotonics, as well as scenarios altering uterotonic use and care-seeking behaviors. We found that substandard uterotonic use contributes to $18.8 million in economic burden annually, including $6.3 million and $4.8 million in out-of-pocket expenditures in public and private sectors, respectively. Annually, the National Health Insurance Scheme bears $1.6 million in costs due to substandard uterotonic use. Substandard uterotonics contribute to $6 million in long-term productivity losses from maternal mortality annually. Improving the quality of uterotonics could reduce 20,000 (11%) PPH cases, 5,000 (11%) severe PPH cases, and 100 (11%) deaths due to PPH annually in Ghana. Ensuring the quality of uterotonics would result in millions of dollars in cost savings and improve maternal health outcomes for the government and families in Ghana. Cost savings from improving uterotonic quality would provide financial protection and help Ghana advance toward Universal Health Coverage.Keywords
Funding Information
- MSD for Mothers
- Global Financing Facility of the World Bank
- Johnson and Johnson Foundation
This publication has 22 references indexed in Scilit:
- A systematic review of the cost‐effectiveness of uterotonic agents for the prevention of postpartum hemorrhageInternational Journal of Gynecology & Obstetrics, 2019
- Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and RomaniaWellcome Open Research, 2019
- Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal BirthNew England Journal of Medicine, 2018
- Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income CountriesJAMA Network Open, 2018
- Risk factors for self‐reported postpartum hemorrhage in Ga East, GhanaInternational Journal of Gynecology & Obstetrics, 2018
- Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysisCochrane Database of Systematic Reviews, 2018
- Analysis of the cost–effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in EcuadorJournal of Comparative Effectiveness Research, 2017
- Quality of oxytocin available in low‐ and middle‐income countries: a systematic review of the literatureBJOG: An International Journal of Obstetrics & Gynaecology, 2016
- Global causes of maternal death: a WHO systematic analysisThe Lancet Global Health, 2014
- Trends in maternal mortality in Tamale Teaching Hospital, Ghana.2011